Evidence map›Paper›PMID 21176163›Full record

ArticleBMC genomics2010

Whole genome sequencing of Saccharomyces cerevisiae: from genotype to phenotype for improved metabolic engineering applications.

José Manuel Otero, Wanwipa Vongsangnak, Mohammad A Asadollahi, Roberto Olivares-Hernandes, Jérôme Maury, Laurent Farinelli, Loïc Barlocher, Magne Osterås, Michel Schalk, Anthony Clark and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 76 citations in OpenAlex.

  1. Comparative functional genomics ofMicrobiology spectrum · 2026
    Article
  2. Engineering robustSynthetic and systems biotechnology · 2025
    Article
  3. Review
  4. Article
  5. Genomic analysis ofMicrobial genomics · 2023
    Article
  6. Article
  7. Article
  8. Characterization of Cold-TolerantMicroorganisms · 2021
    Article
  9. Article
  10. Review
  11. Stepwise engineering ofRSC advances · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Selection of PofFrontiers in microbiology · 2018
    Article
  17. Omics analysis of acetic acid tolerance in Saccharomyces cerevisiae.World journal of microbiology & biotechnology · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 6 countries.

José Manuel OteroDepartment of Chemical and Biological Engineering, Chalmers University of Technology, SE-41296 Gothenburg, Sweden. nielsenj@chalmers.se
Wanwipa Vongsangnak
Mohammad A Asadollahi
Roberto Olivares-Hernandes
Jérôme Maury
Laurent Farinelli
Loïc Barlocher
Magne Osterås
Michel Schalk
Anthony Clark
Jens Nielsen
Chalmers University of Technology · SETechnical University of Denmark · DKFirmenich (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe need for rapid and efficient microbial cell factory design and construction are possible through the enabling technology, metabolic engineering, which is now being facilitated by systems biology approaches. Metabolic engineering is often complimented by directed evolution, where selective pressure is applied to a partially genetically engineered strain to confer a desirable phenotype. The exact genetic modification or resulting genotype that leads to the improved phenotype is often not identified or understood to enable further metabolic engineering.

resultsIn this work we performed whole genome high-throughput sequencing and annotation can be used to identify single nucleotide polymorphisms (SNPs) between Saccharomyces cerevisiae strains S288c and CEN.PK113-7D. The yeast strain S288c was the first eukaryote sequenced, serving as the reference genome for the Saccharomyces Genome Database, while CEN.PK113-7D is a preferred laboratory strain for industrial biotechnology research. A total of 13,787 high-quality SNPs were detected between both strains (reference strain: S288c). Considering only metabolic genes (782 of 5,596 annotated genes), a total of 219 metabolism specific SNPs are distributed across 158 metabolic genes, with 85 of the SNPs being nonsynonymous (e.g., encoding amino acid modifications). Amongst metabolic SNPs detected, there was pathway enrichment in the galactose uptake pathway (GAL1, GAL10) and ergosterol biosynthetic pathway (ERG8, ERG9). Physiological characterization confirmed a strong deficiency in galactose uptake and metabolism in S288c compared to CEN.PK113-7D, and similarly, ergosterol content in CEN.PK113-7D was significantly higher in both glucose and galactose supplemented cultivations compared to S288c. Furthermore, DNA microarray profiling of S288c and CEN.PK113-7D in both glucose and galactose batch cultures did not provide a clear hypothesis for major phenotypes observed, suggesting that genotype to phenotype correlations are manifested post-transcriptionally or post-translationally either through protein concentration and/or function.

conclusionsWith an intensifying need for microbial cell factories that produce a wide array of target compounds, whole genome high-throughput sequencing and annotation for SNP detection can aid in better reducing and defining the metabolic landscape. This work demonstrates direct correlations between genotype and phenotype that provides clear and high-probability of success metabolic engineering targets. The genome sequence, annotation, and a SNP viewer of CEN.PK113-7D are deposited at http://www.sysbio.se/cenpk.

Indexed as

Amino AcidsAmino Acid SequenceBase SequenceChromosomes, FungalErgosterolFungal ProteinsGalactoseGene Expression ProfilingGene Expression Regulation, FungalGenetic EngineeringGenome, FungalGenotypeMolecular Sequence AnnotationMolecular Sequence DataPhenotypePolymorphism, Single NucleotideAmino AcidsErgosterolFungal ProteinsGalactose

Identifiers

PMID21176163
PMCPMC3022925
OpenAlexW2010566861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.